HAE
HAEMONETICS CORP
NYSE · Healthcare · Medical - Instruments & Supplies · US
$118.41
−0.27%Forward multiples
Based on analyst estimates
- P/E forward
- 20.97x
- P/E 2026E
- 22.34x
- P/E 2027E
- 20.40x
- P/E 2028E
- 17.85x
- P/S forward
- 3.69x
Trailing multiples
Trailing twelve months
- P/E TTM
- 57.48x
- PEG TTM
- 0.33x
- Price / book
- 6.44x
- Price / sales
- 3.98x
- Price / cash flow
- 16.42x
Enterprise value
- Enterprise value
- $6.3B
- EV / sales
- 4.69x
- EV / EBITDA
- 24.26x
- EV / EBIT
- 25.79x
- Market cap
- $5.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026